Related Experiment Video
Updated: May 20, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
Raltegravir-induced DRESS syndrome
Pierre Loulergue1, Olivier Mir
1CIC de Vaccinologie Cochin-Pasteur, Hôpital Cochin, 27, rue du Faubourg Saint Jacques, F75014 Paris, France. pierre.loulergue@cch.aphp.fr
Abstract:
DRESS syndrome (drug reaction with eosinophilia and systemic symptoms) is a life-threatening adverse drug reaction. Raltegravir is an integrase inhibitor used in HIV-1 infection. We report on a patient who developed a DRESS syndrome under raltegravir treatment, which was identified as a probable case of DRESS on the basis of Kardaun and Naranjo scores. The presented case is the first description of a proven raltegravir-induced DRESS syndrome.
Related Concept Videos
Graves' Disease I: Introduction
Drug toxicity: Idiosyncratic Reactions
Graves Disease II: Pathophysiology
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Dysrhythmias II: Classification of Tachyarrhythmias
Rheumatic Heart Disease I: Introduction

